Randomization: the forgotten component of the randomized clinical trial
From MaRDI portal
Publication:6625510
DOI10.1002/sim.7901zbMATH Open1545.62525MaRDI QIDQ6625510
Diane Uschner, William F. Rosenberger, Yan-Ying Wang
Publication date: 28 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Sequential monitoring with conditional randomization tests
- Why randomize?
- Design for the Control of Selection Bias
- Significance tests with restricted randomization design
- Discrete Sequential Boundaries for Clinical Trials
- Randomization in Clinical Trials
- Tests for no treatment effect in randomized clinical trials
- The Theory of Response‐Adaptive Randomization in Clinical Trials
- The behaviour of some significance tests under experimental randomization
- Forcing a sequential experiment to be balanced
Related Items (8)
Multinomial Thompson sampling for rating scales and prior considerations for calibrating uncertainty ⋮ Design of randomized clinical trials with a binary endpoint: conditional versus unconditional analyses of a two-by-two table ⋮ The impact of misclassification on covariate-adaptive randomized clinical trials with generalized linear models ⋮ Implementing unequal randomization in clinical trials with heterogeneous treatment costs ⋮ Commentary on: ``Randomization: the forgotten component of the randomized clinical trial ⋮ Rematching on-the-fly: sequential matched randomization and a case for covariate-adjusted randomization ⋮ Randomization tests for multiarmed randomized clinical trials ⋮ Randomization-based inference in the presence of selection bias
This page was built for publication: Randomization: the forgotten component of the randomized clinical trial